vs
Steris（STE）与WESTERN ALLIANCE BANCORPORATION（WAL）财务数据对比。点击上方公司名可切换其他公司
Steris的季度营收约是WESTERN ALLIANCE BANCORPORATION的1.5倍（$1.5B vs $1.0B），WESTERN ALLIANCE BANCORPORATION净利率更高（18.6% vs 12.9%，领先5.7%），WESTERN ALLIANCE BANCORPORATION同比增速更快（31.0% vs 9.2%），过去两年Steris的营收复合增速更高（15.8% vs 14.9%）
Steris plc是一家美爱合资的医疗设备企业，专注于为美国医疗体系提供灭菌服务及外科手术相关产品。其实际运营总部位于美国俄亥俄州门托市，深耕医疗消毒、感染防控、手术耗材等领域，为医疗机构提供专业可靠的医疗解决方案。
Western Alliance Bancorporation是总部位于美国菲尼克斯的区域性银行控股公司，长期深耕美国本土区域金融服务市场，目前已跻身美国最大银行行列，在福布斯发布的美国最佳银行榜单中排名第97位。
STE vs WAL — 直观对比
营收规模更大
STE
是对方的1.5倍
$1.0B
营收增速更快
WAL
高出21.8%
9.2%
净利率更高
WAL
高出5.7%
12.9%
两年增速更快
STE
近两年复合增速
14.9%
损益表 — Q3 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.5B | $1.0B |
| 净利润 | $192.9M | $189.2M |
| 毛利率 | 43.8% | — |
| 营业利润率 | 18.3% | — |
| 净利率 | 12.9% | 18.6% |
| 营收同比 | 9.2% | 31.0% |
| 净利润同比 | 11.2% | -5.0% |
| 每股收益（稀释后） | $1.96 | $1.65 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收STEWAL
| Q1 26 | — | $1.0B | ||
| Q4 25 | $1.5B | $980.9M | ||
| Q3 25 | $1.5B | $938.2M | ||
| Q2 25 | $1.4B | $845.9M | ||
| Q1 25 | $1.5B | $778.0M | ||
| Q4 24 | $1.4B | $838.4M | ||
| Q3 24 | $1.3B | $823.1M | ||
| Q2 24 | $1.3B | $771.8M |
净利润STEWAL
| Q1 26 | — | $189.2M | ||
| Q4 25 | $192.9M | $286.1M | ||
| Q3 25 | $191.9M | $253.4M | ||
| Q2 25 | $177.4M | $230.4M | ||
| Q1 25 | $145.7M | $199.1M | ||
| Q4 24 | $173.5M | $216.9M | ||
| Q3 24 | $150.0M | $199.8M | ||
| Q2 24 | $145.4M | $193.6M |
毛利率STEWAL
| Q1 26 | — | — | ||
| Q4 25 | 43.8% | — | ||
| Q3 25 | 44.2% | — | ||
| Q2 25 | 45.1% | — | ||
| Q1 25 | 43.3% | — | ||
| Q4 24 | 44.5% | — | ||
| Q3 24 | 43.6% | — | ||
| Q2 24 | 44.7% | — |
营业利润率STEWAL
| Q1 26 | — | — | ||
| Q4 25 | 18.3% | 36.3% | ||
| Q3 25 | 18.2% | 33.4% | ||
| Q2 25 | 17.7% | 34.4% | ||
| Q1 25 | 14.6% | 31.7% | ||
| Q4 24 | 17.9% | 30.9% | ||
| Q3 24 | 16.5% | 30.6% | ||
| Q2 24 | 14.5% | 32.1% |
净利率STEWAL
| Q1 26 | — | 18.6% | ||
| Q4 25 | 12.9% | 29.2% | ||
| Q3 25 | 13.1% | 27.0% | ||
| Q2 25 | 12.8% | 27.2% | ||
| Q1 25 | 9.8% | 25.6% | ||
| Q4 24 | 12.7% | 25.9% | ||
| Q3 24 | 11.3% | 24.3% | ||
| Q2 24 | 11.4% | 25.1% |
每股收益（稀释后）STEWAL
| Q1 26 | — | $1.65 | ||
| Q4 25 | $1.96 | $2.59 | ||
| Q3 25 | $1.94 | $2.28 | ||
| Q2 25 | $1.79 | $2.07 | ||
| Q1 25 | $1.48 | $1.79 | ||
| Q4 24 | $1.75 | $1.94 | ||
| Q3 24 | $1.51 | $1.80 | ||
| Q2 24 | $1.46 | $1.75 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $423.7M | — |
| 总债务越低越好 | $1.9B | $4.3B |
| 股东权益账面价值 | $7.2B | $7.9B |
| 总资产 | $10.6B | $98.9B |
| 负债/权益比越低杠杆越低 | 0.27× | 0.54× |
8季度趋势，按日历期对齐
现金及短期投资STEWAL
| Q1 26 | — | — | ||
| Q4 25 | $423.7M | — | ||
| Q3 25 | $319.2M | — | ||
| Q2 25 | $279.7M | — | ||
| Q1 25 | $171.7M | — | ||
| Q4 24 | $155.2M | — | ||
| Q3 24 | $172.2M | — | ||
| Q2 24 | $198.3M | — |
总债务STEWAL
| Q1 26 | — | $4.3B | ||
| Q4 25 | $1.9B | $1.4B | ||
| Q3 25 | $1.9B | $2.9B | ||
| Q2 25 | $1.9B | $2.9B | ||
| Q1 25 | $1.9B | $1.6B | ||
| Q4 24 | $2.0B | $2.4B | ||
| Q3 24 | $2.2B | $1.4B | ||
| Q2 24 | $2.2B | $436.0M |
股东权益STEWAL
| Q1 26 | — | $7.9B | ||
| Q4 25 | $7.2B | $7.7B | ||
| Q3 25 | $7.0B | $7.4B | ||
| Q2 25 | $7.0B | $7.1B | ||
| Q1 25 | $6.6B | $6.9B | ||
| Q4 24 | $6.4B | $6.7B | ||
| Q3 24 | $6.6B | $6.7B | ||
| Q2 24 | $6.4B | $6.3B |
总资产STEWAL
| Q1 26 | — | $98.9B | ||
| Q4 25 | $10.6B | $92.8B | ||
| Q3 25 | $10.4B | $91.0B | ||
| Q2 25 | $10.4B | $86.7B | ||
| Q1 25 | $10.1B | $83.0B | ||
| Q4 24 | $10.0B | $80.9B | ||
| Q3 24 | $10.2B | $80.1B | ||
| Q2 24 | $10.1B | $80.6B |
负债/权益比STEWAL
| Q1 26 | — | 0.54× | ||
| Q4 25 | 0.27× | 0.18× | ||
| Q3 25 | 0.27× | 0.39× | ||
| Q2 25 | 0.27× | 0.41× | ||
| Q1 25 | 0.29× | 0.23× | ||
| Q4 24 | 0.32× | 0.36× | ||
| Q3 24 | 0.33× | 0.21× | ||
| Q2 24 | 0.35× | 0.07× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $298.2M | — |
| 自由现金流经营现金流 - 资本支出 | $199.5M | — |
| 自由现金流率自由现金流/营收 | 13.3% | — |
| 资本支出强度资本支出/营收 | 6.6% | — |
| 现金转化率经营现金流/净利润 | 1.55× | — |
| 过去12个月自由现金流最近4个季度 | $917.1M | — |
8季度趋势，按日历期对齐
经营现金流STEWAL
| Q1 26 | — | — | ||
| Q4 25 | $298.2M | $-2.7B | ||
| Q3 25 | $287.8M | $-597.4M | ||
| Q2 25 | $420.0M | $-357.7M | ||
| Q1 25 | $260.8M | $-1.7B | ||
| Q4 24 | $332.8M | $-2.7B | ||
| Q3 24 | $250.7M | $-1.1B | ||
| Q2 24 | $303.7M | $-745.8M |
自由现金流STEWAL
| Q1 26 | — | — | ||
| Q4 25 | $199.5M | — | ||
| Q3 25 | $201.3M | — | ||
| Q2 25 | $326.4M | — | ||
| Q1 25 | $189.9M | — | ||
| Q4 24 | $243.6M | — | ||
| Q3 24 | $148.8M | — | ||
| Q2 24 | $195.7M | — |
自由现金流率STEWAL
| Q1 26 | — | — | ||
| Q4 25 | 13.3% | — | ||
| Q3 25 | 13.8% | — | ||
| Q2 25 | 23.5% | — | ||
| Q1 25 | 12.8% | — | ||
| Q4 24 | 17.8% | — | ||
| Q3 24 | 11.2% | — | ||
| Q2 24 | 15.3% | — |
资本支出强度STEWAL
| Q1 26 | — | — | ||
| Q4 25 | 6.6% | — | ||
| Q3 25 | 5.9% | — | ||
| Q2 25 | 6.7% | — | ||
| Q1 25 | 4.8% | — | ||
| Q4 24 | 6.5% | — | ||
| Q3 24 | 7.7% | — | ||
| Q2 24 | 8.4% | — |
现金转化率STEWAL
| Q1 26 | — | — | ||
| Q4 25 | 1.55× | -9.36× | ||
| Q3 25 | 1.50× | -2.36× | ||
| Q2 25 | 2.37× | -1.55× | ||
| Q1 25 | 1.79× | -8.31× | ||
| Q4 24 | 1.92× | -12.64× | ||
| Q3 24 | 1.67× | -5.35× | ||
| Q2 24 | 2.09× | -3.85× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
STE
| Servicerevenues | $404.7M | 27% |
| Consumablerevenues | $387.1M | 26% |
| Applied Sterilization Technologies | $286.6M | 19% |
| Capitalequipmentrevenues | $272.1M | 18% |
| Life Science | $145.8M | 10% |
WAL
暂无分部数据
